Feedback / Questions
margetuximab (MGAH 22) - MacroGenics
Margetuximab: Acceptance of regulatory submission for HER2 + metastatic breast cancer in Q1 2020
(Macrogenics)
-
Jan 17, 2020 -
Corporate Presentation: PDUFA action date for HER2 + metastatic breast cancer in Q4 2020
BLA • PDUFA date
http://ir.macrogenics.com/static-files/c73fd3d3-6a17-4f04-95d9-3d6c39eb7411
Jan 17, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious